JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2008, 57(6):269-274

The effect of lipophilic carrier concentration on hydrophilic-lipophilic matrix systems characteristics

K. Dvořáčková*, M. Rabišková, R. Masteiková, L. Okáčová
Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta, Ústav technologie léků

The present experimental paper aimed to examine the effect of lipophilic carrier concentration on diclofenac sodium prolonged release from hydrophilic-lipophilic matrix tablets with respect to the optimization of its dissolution profile in vitro. The lipophilic carrier was cetyl alcohol contemporaneously acting as the melting binder in thermoplastic granulation, povidone was used as the gel-forming agent, sucrose or lactose were fillers. The obtained results indicated that cetyl alcohol concentration influenced both characteristics of the granulates and the tablets. The dissolution profile of sucrose samples was affected statistically significantly by cetyl alcohol concentration, in the case of lactose samples only when a higher cetyl alcohol concentration was used. The increasing concentration of cetyl alcohol led to a slower drug release. From the obtained results it is apparent that sucrose samples released drug faster in comparison with the lactose monohydrate ones, especially when a lower lipid carrier concentration was used.

Keywords: matrix tablets; controlled release; cetyl alcohol; melt granulation

Received: October 6, 2008; Accepted: October 29, 2008; Published: June 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dvořáčková K, Rabišková M, Masteiková R, Okáčová L. The effect of lipophilic carrier concentration on hydrophilic-lipophilic matrix systems characteristics. Čes. slov. farm. 2008;57(6):269-274.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Rabišková, M.: Remedia, 2007; 17, 188-192. Go to original source...
    2. Raymond, C., et al.: Handbook of Pharmaceutical Excipients. 5. ed. London: The Pharmaceutical Press, 2006, s. 651.
    3. Rabišková, M., Komárek, P. et al.: Technologie léků. 3. přeprac. a dopl. vyd. Praha: Galén, 2006, s. 399.
    4. Dvořáčková, K. et al.: Čes. slov. Farm., 2007; 56, 129-134. Go to original source...
    5. Bozi, D. Z., Vreer, F., Kozjek, F.: Eur. J. Pharm. Sci., 1997; 5, 163-169. Go to original source...
    6. Gil, E. C. et al.: Int. J. Pharm., 2006; 317, 32-39. Go to original source... Go to PubMed...
    7. Gren, T., Nyströc, C.: Int. J. Pharm., 1999; 184, 7-19. Go to original source... Go to PubMed...
    8. Maheshwari, M. et al.: Int. J. Pharm., 2003; 261, 57-67. Go to original source... Go to PubMed...
    9. Paradkar, A. et al.: AAPS Pharm. Sci. Tech., 2003; 4(4) Art 65. Go to original source... Go to PubMed...
    10. Devaraj, G. N. et al.: J Colloid Interface Sci., 2002; 251, 360-365. Go to original source... Go to PubMed...
    11. Savickas A., Bernatonienė J.: Medicina (Kaunas), 2005; 41(3), 226.
    12. Avachnnt, A., Kotwal, V.: AAPS PharmSciTech, 2007, 8, Art. 88 (http://www.aapspharmscitech.org).
    13. Chopra, S., Patil, G. V., Motwani, S. K.: Eur. J. Pharm. Biopharm., 2007, 66, 73-82. Go to original source... Go to PubMed...
    14. Singh, B., Chakkal, S. K., Ahuja, N.: AAPS Pharm. Sci. Tech., 2006; 7 (1) Art. 3 (http://www.aapspharmscitech. org). Go to original source...
    15. Pereira de Souza, T. et al.: AAPS Pharm. Sci. Tech, 2007, 8(2), Art. 34 (www.aapspharmscitech.org).
    16. Saravanan, M. et al.: Biol. Pharm. Bull., 2002; 25, 541-545. Go to original source... Go to PubMed...
    17. Rabišková, M. et al.: Čes. slov. Farm., 2003; 52, 211-217.

    Return to the content


    Czech and Slovak Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.